

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.33522016 |
| 2 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.33522016 |
| 3 | behavioral response to nicotine (GO:0035095) | 4.21616042 |
| 4 | protein complex biogenesis (GO:0070271) | 4.21033370 |
| 5 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.08083021 |
| 6 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 4.01114889 |
| 7 | NADH dehydrogenase complex assembly (GO:0010257) | 4.01114889 |
| 8 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 4.01114889 |
| 9 | valine metabolic process (GO:0006573) | 3.92783056 |
| 10 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 3.84284842 |
| 11 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 3.84284842 |
| 12 | ribosomal small subunit assembly (GO:0000028) | 3.80674161 |
| 13 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.77416402 |
| 14 | viral transcription (GO:0019083) | 3.77000859 |
| 15 | preassembly of GPI anchor in ER membrane (GO:0016254) | 3.72209047 |
| 16 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.59357358 |
| 17 | translational termination (GO:0006415) | 3.55382000 |
| 18 | L-fucose catabolic process (GO:0042355) | 3.53191623 |
| 19 | fucose catabolic process (GO:0019317) | 3.53191623 |
| 20 | L-fucose metabolic process (GO:0042354) | 3.53191623 |
| 21 | protein targeting to ER (GO:0045047) | 3.52381423 |
| 22 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.51486051 |
| 23 | cytidine deamination (GO:0009972) | 3.50518021 |
| 24 | cytidine metabolic process (GO:0046087) | 3.50518021 |
| 25 | cytidine catabolic process (GO:0006216) | 3.50518021 |
| 26 | cotranslational protein targeting to membrane (GO:0006613) | 3.49454317 |
| 27 | ubiquinone biosynthetic process (GO:0006744) | 3.49062604 |
| 28 | cytochrome complex assembly (GO:0017004) | 3.46222985 |
| 29 | tryptophan catabolic process (GO:0006569) | 3.43122266 |
| 30 | indole-containing compound catabolic process (GO:0042436) | 3.43122266 |
| 31 | indolalkylamine catabolic process (GO:0046218) | 3.43122266 |
| 32 | respiratory chain complex IV assembly (GO:0008535) | 3.38277264 |
| 33 | protein localization to endoplasmic reticulum (GO:0070972) | 3.36240434 |
| 34 | signal peptide processing (GO:0006465) | 3.35856536 |
| 35 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.33302027 |
| 36 | positive regulation of defense response to virus by host (GO:0002230) | 3.32703316 |
| 37 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.32515343 |
| 38 | cornea development in camera-type eye (GO:0061303) | 3.29446480 |
| 39 | positive regulation of prostaglandin secretion (GO:0032308) | 3.27350778 |
| 40 | iron-sulfur cluster assembly (GO:0016226) | 3.27166904 |
| 41 | metallo-sulfur cluster assembly (GO:0031163) | 3.27166904 |
| 42 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.22503707 |
| 43 | ATP synthesis coupled proton transport (GO:0015986) | 3.22503707 |
| 44 | axoneme assembly (GO:0035082) | 3.20403815 |
| 45 | platelet dense granule organization (GO:0060155) | 3.19012671 |
| 46 | pseudouridine synthesis (GO:0001522) | 3.17224034 |
| 47 | protein-cofactor linkage (GO:0018065) | 3.14252716 |
| 48 | kynurenine metabolic process (GO:0070189) | 3.13702889 |
| 49 | indolalkylamine metabolic process (GO:0006586) | 3.13280030 |
| 50 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 3.13179386 |
| 51 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.12122377 |
| 52 | mannosylation (GO:0097502) | 3.11370425 |
| 53 | cellular ketone body metabolic process (GO:0046950) | 3.08569227 |
| 54 | regulation of sequestering of triglyceride (GO:0010889) | 3.07863839 |
| 55 | electron transport chain (GO:0022900) | 3.06992626 |
| 56 | translational elongation (GO:0006414) | 3.02440105 |
| 57 | ubiquinone metabolic process (GO:0006743) | 3.01433587 |
| 58 | mitochondrial calcium ion transport (GO:0006851) | 3.00997989 |
| 59 | low-density lipoprotein particle clearance (GO:0034383) | 2.99095096 |
| 60 | respiratory electron transport chain (GO:0022904) | 2.97648393 |
| 61 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.92393783 |
| 62 | base-excision repair, AP site formation (GO:0006285) | 2.92325307 |
| 63 | ribosomal small subunit biogenesis (GO:0042274) | 2.91522029 |
| 64 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 2.91011255 |
| 65 | L-phenylalanine metabolic process (GO:0006558) | 2.90891060 |
| 66 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.90891060 |
| 67 | positive regulation of fatty acid transport (GO:2000193) | 2.90004338 |
| 68 | tryptophan metabolic process (GO:0006568) | 2.89423975 |
| 69 | cellular response to zinc ion (GO:0071294) | 2.88025236 |
| 70 | quinone biosynthetic process (GO:1901663) | 2.86967206 |
| 71 | GPI anchor metabolic process (GO:0006505) | 2.85485279 |
| 72 | heme biosynthetic process (GO:0006783) | 2.84685958 |
| 73 | fatty acid beta-oxidation (GO:0006635) | 2.84409233 |
| 74 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 2.83811153 |
| 75 | negative regulation of telomere maintenance (GO:0032205) | 2.83601394 |
| 76 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.83277413 |
| 77 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 2.82992415 |
| 78 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.82053279 |
| 79 | piRNA metabolic process (GO:0034587) | 2.81093070 |
| 80 | positive regulation of icosanoid secretion (GO:0032305) | 2.80418761 |
| 81 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 2.79079131 |
| 82 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.78060874 |
| 83 | detection of light stimulus involved in visual perception (GO:0050908) | 2.78060874 |
| 84 | viral life cycle (GO:0019058) | 2.77873092 |
| 85 | GPI anchor biosynthetic process (GO:0006506) | 2.73461035 |
| 86 | branched-chain amino acid metabolic process (GO:0009081) | 2.72389897 |
| 87 | epithelial cilium movement (GO:0003351) | 2.72015170 |
| 88 | ketone body metabolic process (GO:1902224) | 2.71962857 |
| 89 | L-phenylalanine catabolic process (GO:0006559) | 2.71017035 |
| 90 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.71017035 |
| 91 | cellular biogenic amine catabolic process (GO:0042402) | 2.70910445 |
| 92 | amine catabolic process (GO:0009310) | 2.70910445 |
| 93 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.70536250 |
| 94 | autophagic vacuole fusion (GO:0000046) | 2.68723417 |
| 95 | chaperone-mediated protein transport (GO:0072321) | 2.67238718 |
| 96 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 2.66995935 |
| 97 | regulation of triglyceride catabolic process (GO:0010896) | 2.66876381 |
| 98 | response to pheromone (GO:0019236) | 2.66700434 |
| 99 | regulation of cilium movement (GO:0003352) | 2.64212243 |
| 100 | branched-chain amino acid catabolic process (GO:0009083) | 2.63938921 |
| 101 | C-terminal protein lipidation (GO:0006501) | 2.62275486 |
| 102 | peptidyl-histidine modification (GO:0018202) | 2.58936171 |
| 103 | heme metabolic process (GO:0042168) | 2.58385595 |
| 104 | multicellular organism reproduction (GO:0032504) | 2.56656576 |
| 105 | fatty acid oxidation (GO:0019395) | 2.55591163 |
| 106 | termination of RNA polymerase III transcription (GO:0006386) | 2.54872953 |
| 107 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.54872953 |
| 108 | regulation of metalloenzyme activity (GO:0048552) | 2.54039971 |
| 109 | triglyceride catabolic process (GO:0019433) | 2.53482733 |
| 110 | fatty acid catabolic process (GO:0009062) | 2.52998985 |
| 111 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.51466375 |
| 112 | GTP biosynthetic process (GO:0006183) | 2.49730288 |
| 113 | lipid oxidation (GO:0034440) | 2.49574479 |
| 114 | arginine metabolic process (GO:0006525) | 2.47899898 |
| 115 | NAD biosynthetic process (GO:0009435) | 2.47274067 |
| 116 | adenosine metabolic process (GO:0046085) | 2.46898503 |
| 117 | cellular protein complex disassembly (GO:0043624) | 2.46674715 |
| 118 | protein targeting to membrane (GO:0006612) | 2.45700493 |
| 119 | proton transport (GO:0015992) | 2.45425863 |
| 120 | negative regulation of T cell differentiation in thymus (GO:0033085) | 2.45238730 |
| 121 | deoxyribonucleotide catabolic process (GO:0009264) | 2.45069532 |
| 122 | sulfur amino acid catabolic process (GO:0000098) | 2.44894169 |
| 123 | sequestering of actin monomers (GO:0042989) | 2.44113301 |
| 124 | organelle membrane fusion (GO:0090174) | 2.43866957 |
| 125 | positive regulation of protein homodimerization activity (GO:0090073) | 2.42757790 |
| 126 | tRNA processing (GO:0008033) | 2.42447137 |
| 127 | hydrogen ion transmembrane transport (GO:1902600) | 2.42198412 |
| 128 | regulation of cholesterol storage (GO:0010885) | 2.42164860 |
| 129 | arginine catabolic process (GO:0006527) | 2.41470630 |
| 130 | estrogen biosynthetic process (GO:0006703) | 2.40803848 |
| 131 | DNA methylation involved in gamete generation (GO:0043046) | 2.40166460 |
| 132 | hydrogen transport (GO:0006818) | 2.39662513 |
| 133 | negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244) | 2.39193760 |
| 134 | tRNA modification (GO:0006400) | 2.39006709 |
| 135 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.38316227 |
| 136 | amino acid salvage (GO:0043102) | 2.36104781 |
| 137 | L-methionine salvage (GO:0071267) | 2.36104781 |
| 138 | L-methionine biosynthetic process (GO:0071265) | 2.36104781 |
| 139 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 2.35134795 |
| 140 | pentose-phosphate shunt (GO:0006098) | 2.34873864 |
| 141 | regulation of defense response to virus by host (GO:0050691) | 2.34115147 |
| 142 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 2.33841785 |
| 143 | protein neddylation (GO:0045116) | 2.33125861 |
| 144 | C-terminal protein amino acid modification (GO:0018410) | 2.32863656 |
| 145 | desmosome organization (GO:0002934) | 2.30329836 |
| 146 | aldehyde catabolic process (GO:0046185) | 2.29312838 |
| 147 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.27034112 |
| 148 | regulation of superoxide anion generation (GO:0032928) | 2.25741262 |
| 149 | translational initiation (GO:0006413) | 2.25290857 |
| 150 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.25244321 |
| 151 | response to type I interferon (GO:0034340) | 2.25183140 |
| 152 | plasma lipoprotein particle clearance (GO:0034381) | 2.24445964 |
| 153 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.24098642 |
| 154 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.24098642 |
| 155 | cysteine metabolic process (GO:0006534) | 2.23091154 |
| 156 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.22690168 |
| 157 | tricarboxylic acid metabolic process (GO:0072350) | 2.22536110 |
| 158 | ethanol oxidation (GO:0006069) | 2.22346577 |
| 159 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.22227154 |
| 160 | negative regulation of lipid storage (GO:0010888) | 2.22193212 |
| 161 | type I interferon signaling pathway (GO:0060337) | 2.21929520 |
| 162 | cellular response to type I interferon (GO:0071357) | 2.21929520 |
| 163 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.21746087 |
| 164 | neutral lipid catabolic process (GO:0046461) | 2.20364853 |
| 165 | acylglycerol catabolic process (GO:0046464) | 2.20364853 |
| 166 | brown fat cell differentiation (GO:0050873) | 2.20101405 |
| 167 | glyoxylate metabolic process (GO:0046487) | 2.19260805 |
| 168 | negative regulation of protein autophosphorylation (GO:0031953) | 2.19053813 |
| 169 | response to interferon-beta (GO:0035456) | 2.18413444 |
| 170 | amyloid precursor protein catabolic process (GO:0042987) | 2.17499318 |
| 171 | regulation of cholesterol metabolic process (GO:0090181) | 2.15987750 |
| 172 | aromatic amino acid family catabolic process (GO:0009074) | 2.15952126 |
| 173 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.15069014 |
| 174 | leukocyte aggregation (GO:0070486) | 2.14690399 |
| 175 | NADPH regeneration (GO:0006740) | 2.14655350 |
| 176 | monocarboxylic acid catabolic process (GO:0072329) | 2.14278897 |
| 177 | regulation of triglyceride metabolic process (GO:0090207) | 2.14231845 |
| 178 | ethanol metabolic process (GO:0006067) | 2.12074552 |
| 179 | negative regulation of phagocytosis (GO:0050765) | 2.11679567 |
| 180 | regulation of cholesterol esterification (GO:0010872) | 2.11425000 |
| 181 | neutrophil activation involved in immune response (GO:0002283) | 2.10670494 |
| 182 | positive regulation of lipid catabolic process (GO:0050996) | 2.10615826 |
| 183 | positive regulation of fatty acid oxidation (GO:0046321) | 2.10253861 |
| 184 | porphyrin-containing compound biosynthetic process (GO:0006779) | 2.08962920 |
| 185 | DNA deamination (GO:0045006) | 2.08728286 |
| 186 | transcytosis (GO:0045056) | 2.08077841 |
| 187 | alpha-linolenic acid metabolic process (GO:0036109) | 2.06761748 |
| 188 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.06200228 |
| 189 | biotin metabolic process (GO:0006768) | 2.05893677 |
| 190 | 2-oxoglutarate metabolic process (GO:0006103) | 2.05015602 |
| 191 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.04260801 |
| 192 | regulation of superoxide metabolic process (GO:0090322) | 2.03740753 |
| 193 | pentose metabolic process (GO:0019321) | 2.02688667 |
| 194 | reactive oxygen species biosynthetic process (GO:1903409) | 2.02367889 |
| 195 | protein retention in ER lumen (GO:0006621) | 2.01919309 |
| 196 | primary alcohol catabolic process (GO:0034310) | 2.01863840 |
| 197 | xenobiotic catabolic process (GO:0042178) | 2.01806708 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.00212801 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.90741034 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.58585222 |
| 4 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.49899010 |
| 5 | ZNF274_21170338_ChIP-Seq_K562_Hela | 3.45535816 |
| 6 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 3.24273584 |
| 7 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.79412498 |
| 8 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.75313197 |
| 9 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.72289610 |
| 10 | VDR_22108803_ChIP-Seq_LS180_Human | 2.37287761 |
| 11 | * TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.34697199 |
| 12 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.33994032 |
| 13 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.31064509 |
| 14 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.21256734 |
| 15 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.18842737 |
| 16 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.18730982 |
| 17 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.08716138 |
| 18 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.99916569 |
| 19 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.99136150 |
| 20 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.95886822 |
| 21 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.93575147 |
| 22 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.92186093 |
| 23 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.90131605 |
| 24 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.89417838 |
| 25 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.86560895 |
| 26 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.85450048 |
| 27 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.84162895 |
| 28 | ERA_21632823_ChIP-Seq_H3396_Human | 1.82550815 |
| 29 | * VDR_23849224_ChIP-Seq_CD4+_Human | 1.82037291 |
| 30 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.79368489 |
| 31 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.77741024 |
| 32 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.77329789 |
| 33 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.77068558 |
| 34 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.76139118 |
| 35 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.75968553 |
| 36 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.75163376 |
| 37 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.74829285 |
| 38 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.74609568 |
| 39 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.74137157 |
| 40 | * TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.70140844 |
| 41 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.66582652 |
| 42 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.64027636 |
| 43 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.62374422 |
| 44 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.61258740 |
| 45 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.59373096 |
| 46 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.58889546 |
| 47 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.58430332 |
| 48 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.57822714 |
| 49 | * CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.57821955 |
| 50 | MAF_26560356_Chip-Seq_TH1_Human | 1.56313632 |
| 51 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.55115307 |
| 52 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.54100706 |
| 53 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.51676184 |
| 54 | AR_20517297_ChIP-Seq_VCAP_Human | 1.49715132 |
| 55 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.49641026 |
| 56 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.49495413 |
| 57 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.49495413 |
| 58 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.48708527 |
| 59 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.47652649 |
| 60 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.43003951 |
| 61 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.42492909 |
| 62 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.41728600 |
| 63 | P300_27268052_Chip-Seq_Bcells_Human | 1.40883528 |
| 64 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.40854735 |
| 65 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.40460512 |
| 66 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.39842213 |
| 67 | P68_20966046_ChIP-Seq_HELA_Human | 1.39411398 |
| 68 | * P53_21459846_ChIP-Seq_SAOS-2_Human | 1.38926380 |
| 69 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.38054705 |
| 70 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.38010234 |
| 71 | MYC_19829295_ChIP-Seq_ESCs_Human | 1.36772238 |
| 72 | NCOR_22424771_ChIP-Seq_293T_Human | 1.35629134 |
| 73 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.35530757 |
| 74 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.35470194 |
| 75 | * FOXP3_21729870_ChIP-Seq_TREG_Human | 1.34740401 |
| 76 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.33907256 |
| 77 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.33399455 |
| 78 | OCT4_20526341_ChIP-Seq_ESCs_Human | 1.32985449 |
| 79 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.32347072 |
| 80 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.31780313 |
| 81 | * CTCF_20526341_ChIP-Seq_ESCs_Human | 1.31542491 |
| 82 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.30896295 |
| 83 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.30062404 |
| 84 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.29599005 |
| 85 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.29451266 |
| 86 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.28763599 |
| 87 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.28734776 |
| 88 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.28314659 |
| 89 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.28285328 |
| 90 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.28028642 |
| 91 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.25928650 |
| 92 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.25041597 |
| 93 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.24980328 |
| 94 | * RAC3_21632823_ChIP-Seq_H3396_Human | 1.24316480 |
| 95 | * PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 1.23715403 |
| 96 | MYB_26560356_Chip-Seq_TH2_Human | 1.22825921 |
| 97 | MYC_22102868_ChIP-Seq_BL_Human | 1.22021262 |
| 98 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.21495230 |
| 99 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.21227225 |
| 100 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.20623182 |
| 101 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.19943204 |
| 102 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.19651142 |
| 103 | HOXB7_26014856_ChIP-Seq_BT474_Human | 1.19261351 |
| 104 | UTX_26944678_Chip-Seq_JUKART_Human | 1.19143653 |
| 105 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.18489298 |
| 106 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.17696504 |
| 107 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.17625088 |
| 108 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.17403269 |
| 109 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.17255125 |
| 110 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 1.16915466 |
| 111 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.16672097 |
| 112 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.16510275 |
| 113 | GATA3_26560356_Chip-Seq_TH2_Human | 1.15740521 |
| 114 | * MAF_26560356_Chip-Seq_TH2_Human | 1.15645976 |
| 115 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.15144611 |
| 116 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.14239285 |
| 117 | * YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.13835095 |
| 118 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.13068145 |
| 119 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.12772293 |
| 120 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.12483409 |
| 121 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.12348551 |
| 122 | ERG_20517297_ChIP-Seq_VCAP_Human | 1.12281035 |
| 123 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.12162739 |
| 124 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 1.11052635 |
| 125 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.10437553 |
| 126 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.10347366 |
| 127 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.10263787 |
| 128 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.08869594 |
| 129 | GATA1_22025678_ChIP-Seq_K562_Human | 1.07765548 |
| 130 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.06906365 |
| 131 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.05829061 |
| 132 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.05528388 |
| 133 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 1.04755229 |
| 134 | MYB_26560356_Chip-Seq_TH1_Human | 1.04635450 |
| 135 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.04462123 |
| 136 | SA1_27219007_Chip-Seq_Bcells_Human | 1.04304485 |
| 137 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.04119310 |
| 138 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.03871613 |
| 139 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.03477061 |
| 140 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.03186459 |
| 141 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.03104957 |
| 142 | SOX2_21211035_ChIP-Seq_LN229_Human | 1.02970373 |
| 143 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.00993345 |
| 144 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.99999266 |
| 145 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 0.99901291 |
| 146 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 0.99653456 |
| 147 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.99457911 |
| 148 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.98316995 |
| 149 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 0.97930646 |
| 150 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.97784867 |
| 151 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.97267871 |
| 152 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.97225755 |
| 153 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.97161260 |
| 154 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.96887323 |
| 155 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.96863662 |
| 156 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 0.95705226 |
| 157 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.95672569 |
| 158 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.95399554 |
| 159 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.95307359 |
| 160 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.95303571 |
| 161 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.95077136 |
| 162 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.94872724 |
| 163 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.94496339 |
| 164 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.94157551 |
| 165 | DCP1A_22483619_ChIP-Seq_HELA_Human | 0.93708622 |
| 166 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 0.93656569 |
| 167 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.93317942 |
| 168 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.93306411 |
| 169 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 0.93237099 |
| 170 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 0.92717583 |
| 171 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.92613178 |
| 172 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.92405423 |
| 173 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.91776161 |
| 174 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.91422400 |
| 175 | * ATF3_27146783_Chip-Seq_COLON_Human | 0.90918356 |
| 176 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.90258501 |
| 177 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.89429488 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002653_abnormal_ependyma_morphology | 3.16367363 |
| 2 | MP0003011_delayed_dark_adaptation | 2.52494491 |
| 3 | MP0001968_abnormal_touch/_nociception | 2.52267443 |
| 4 | MP0001835_abnormal_antigen_presentation | 2.50181437 |
| 5 | MP0002139_abnormal_hepatobiliary_system | 2.50003905 |
| 6 | MP0005645_abnormal_hypothalamus_physiol | 2.43123659 |
| 7 | MP0000685_abnormal_immune_system | 2.41440942 |
| 8 | MP0002736_abnormal_nociception_after | 2.30920964 |
| 9 | MP0003724_increased_susceptibility_to | 2.23120555 |
| 10 | MP0003191_abnormal_cellular_cholesterol | 2.20864269 |
| 11 | MP0002876_abnormal_thyroid_physiology | 2.15882955 |
| 12 | MP0008872_abnormal_physiological_respon | 2.14727014 |
| 13 | MP0009785_altered_susceptibility_to | 2.13905669 |
| 14 | MP0003186_abnormal_redox_activity | 2.08889789 |
| 15 | MP0003806_abnormal_nucleotide_metabolis | 2.08113349 |
| 16 | MP0005360_urolithiasis | 2.07781570 |
| 17 | MP0006292_abnormal_olfactory_placode | 2.06889011 |
| 18 | MP0003436_decreased_susceptibility_to | 1.98721847 |
| 19 | MP0005551_abnormal_eye_electrophysiolog | 1.96479198 |
| 20 | MP0002638_abnormal_pupillary_reflex | 1.93695162 |
| 21 | MP0001873_stomach_inflammation | 1.92083316 |
| 22 | MP0001986_abnormal_taste_sensitivity | 1.88575399 |
| 23 | MP0003136_yellow_coat_color | 1.88477013 |
| 24 | MP0005670_abnormal_white_adipose | 1.87889650 |
| 25 | MP0001790_abnormal_immune_system | 1.87086825 |
| 26 | MP0005387_immune_system_phenotype | 1.87086825 |
| 27 | MP0005075_abnormal_melanosome_morpholog | 1.86897480 |
| 28 | MP0009840_abnormal_foam_cell | 1.85136688 |
| 29 | MP0005365_abnormal_bile_salt | 1.79820134 |
| 30 | MP0002166_altered_tumor_susceptibility | 1.78587595 |
| 31 | MP0008438_abnormal_cutaneous_collagen | 1.78133984 |
| 32 | MP0004145_abnormal_muscle_electrophysio | 1.72242687 |
| 33 | MP0004043_abnormal_pH_regulation | 1.71602843 |
| 34 | MP0008877_abnormal_DNA_methylation | 1.70424807 |
| 35 | MP0005377_hearing/vestibular/ear_phenot | 1.69857953 |
| 36 | MP0003878_abnormal_ear_physiology | 1.69857953 |
| 37 | MP0004147_increased_porphyrin_level | 1.68944663 |
| 38 | MP0000372_irregular_coat_pigmentation | 1.67670386 |
| 39 | MP0001919_abnormal_reproductive_system | 1.67221548 |
| 40 | MP0002277_abnormal_respiratory_mucosa | 1.65835048 |
| 41 | MP0005025_abnormal_response_to | 1.65247953 |
| 42 | MP0005671_abnormal_response_to | 1.64082053 |
| 43 | MP0002148_abnormal_hypersensitivity_rea | 1.63146880 |
| 44 | MP0002138_abnormal_hepatobiliary_system | 1.61757902 |
| 45 | MP0002102_abnormal_ear_morphology | 1.60874258 |
| 46 | MP0005000_abnormal_immune_tolerance | 1.57636882 |
| 47 | MP0005451_abnormal_body_composition | 1.56650986 |
| 48 | MP0004185_abnormal_adipocyte_glucose | 1.53852848 |
| 49 | MP0005275_abnormal_skin_tensile | 1.51079553 |
| 50 | MP0001853_heart_inflammation | 1.50978613 |
| 51 | MP0004142_abnormal_muscle_tone | 1.50045649 |
| 52 | MP0005666_abnormal_adipose_tissue | 1.49705634 |
| 53 | MP0003763_abnormal_thymus_physiology | 1.49663025 |
| 54 | MP0001800_abnormal_humoral_immune | 1.49603149 |
| 55 | MP0005083_abnormal_biliary_tract | 1.47567601 |
| 56 | MP0005646_abnormal_pituitary_gland | 1.46285304 |
| 57 | MP0002837_dystrophic_cardiac_calcinosis | 1.45669835 |
| 58 | MP0006072_abnormal_retinal_apoptosis | 1.45358356 |
| 59 | MP0005389_reproductive_system_phenotype | 1.44921713 |
| 60 | MP0008789_abnormal_olfactory_epithelium | 1.44103995 |
| 61 | MP0001905_abnormal_dopamine_level | 1.41791032 |
| 62 | MP0004885_abnormal_endolymph | 1.41277179 |
| 63 | MP0002234_abnormal_pharynx_morphology | 1.40824318 |
| 64 | MP0004133_heterotaxia | 1.40802284 |
| 65 | MP0002006_tumorigenesis | 1.38681036 |
| 66 | MP0005085_abnormal_gallbladder_physiolo | 1.37617015 |
| 67 | MP0005174_abnormal_tail_pigmentation | 1.37319356 |
| 68 | MP0002452_abnormal_antigen_presenting | 1.37190321 |
| 69 | MP0002419_abnormal_innate_immunity | 1.35474480 |
| 70 | MP0005253_abnormal_eye_physiology | 1.34852505 |
| 71 | MP0004947_skin_inflammation | 1.33983543 |
| 72 | MP0002796_impaired_skin_barrier | 1.33509970 |
| 73 | MP0002723_abnormal_immune_serum | 1.33065244 |
| 74 | MP0000858_altered_metastatic_potential | 1.32961284 |
| 75 | MP0009379_abnormal_foot_pigmentation | 1.32865184 |
| 76 | MP0003705_abnormal_hypodermis_morpholog | 1.32276421 |
| 77 | MP0001764_abnormal_homeostasis | 1.31164325 |
| 78 | MP0004130_abnormal_muscle_cell | 1.29973807 |
| 79 | MP0005058_abnormal_lysosome_morphology | 1.29805672 |
| 80 | MP0003656_abnormal_erythrocyte_physiolo | 1.28942873 |
| 81 | MP0003787_abnormal_imprinting | 1.28048223 |
| 82 | MP0003195_calcinosis | 1.28036012 |
| 83 | MP0006082_CNS_inflammation | 1.27486128 |
| 84 | MP0001485_abnormal_pinna_reflex | 1.26319777 |
| 85 | MP0009643_abnormal_urine_homeostasis | 1.25623355 |
| 86 | MP0008995_early_reproductive_senescence | 1.25063578 |
| 87 | MP0002420_abnormal_adaptive_immunity | 1.24646862 |
| 88 | MP0001819_abnormal_immune_cell | 1.24288845 |
| 89 | MP0005375_adipose_tissue_phenotype | 1.22526129 |
| 90 | MP0002933_joint_inflammation | 1.22524035 |
| 91 | MP0001666_abnormal_nutrient_absorption | 1.22476030 |
| 92 | MP0000343_altered_response_to | 1.22281089 |
| 93 | MP0001501_abnormal_sleep_pattern | 1.21276219 |
| 94 | MP0002405_respiratory_system_inflammati | 1.21254247 |
| 95 | MP0010155_abnormal_intestine_physiology | 1.21076843 |
| 96 | MP0001845_abnormal_inflammatory_respons | 1.20260161 |
| 97 | MP0002160_abnormal_reproductive_system | 1.20172313 |
| 98 | MP0000609_abnormal_liver_physiology | 1.19514038 |
| 99 | MP0008469_abnormal_protein_level | 1.19467589 |
| 100 | MP0003303_peritoneal_inflammation | 1.19158477 |
| 101 | MP0010329_abnormal_lipoprotein_level | 1.18632028 |
| 102 | MP0008875_abnormal_xenobiotic_pharmacok | 1.18473454 |
| 103 | MP0001533_abnormal_skeleton_physiology | 1.17883721 |
| 104 | MP0009333_abnormal_splenocyte_physiolog | 1.17188403 |
| 105 | MP0009745_abnormal_behavioral_response | 1.14932471 |
| 106 | MP0005332_abnormal_amino_acid | 1.14431998 |
| 107 | MP0003646_muscle_fatigue | 1.14328738 |
| 108 | MP0003453_abnormal_keratinocyte_physiol | 1.13760277 |
| 109 | MP0002877_abnormal_melanocyte_morpholog | 1.13557208 |
| 110 | MP0001879_abnormal_lymphatic_vessel | 1.11663871 |
| 111 | MP0006036_abnormal_mitochondrial_physio | 1.10953607 |
| 112 | MP0002060_abnormal_skin_morphology | 1.10613680 |
| 113 | MP0003828_pulmonary_edema | 1.10358649 |
| 114 | MP0003300_gastrointestinal_ulcer | 1.09326584 |
| 115 | MP0005319_abnormal_enzyme/_coenzyme | 1.09005649 |
| 116 | MP0000538_abnormal_urinary_bladder | 1.08038352 |
| 117 | MP0000749_muscle_degeneration | 1.07814401 |
| 118 | MP0005410_abnormal_fertilization | 1.07432756 |
| 119 | MP0002938_white_spotting | 1.07365010 |
| 120 | MP0000013_abnormal_adipose_tissue | 1.06164746 |
| 121 | MP0000427_abnormal_hair_cycle | 1.04042785 |
| 122 | MP0006276_abnormal_autonomic_nervous | 1.03970006 |
| 123 | MP0005464_abnormal_platelet_physiology | 1.03553345 |
| 124 | MP0002118_abnormal_lipid_homeostasis | 1.03068876 |
| 125 | MP0001502_abnormal_circadian_rhythm | 1.01460486 |
| 126 | MP0006054_spinal_hemorrhage | 1.01374792 |
| 127 | MP0010386_abnormal_urinary_bladder | 1.00718389 |
| 128 | MP0004742_abnormal_vestibular_system | 0.99695071 |
| 129 | MP0000631_abnormal_neuroendocrine_gland | 0.99472533 |
| 130 | MP0002971_abnormal_brown_adipose | 0.98585759 |
| 131 | MP0005501_abnormal_skin_physiology | 0.97579931 |
| 132 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.97576470 |
| 133 | MP0009763_increased_sensitivity_to | 0.97338397 |
| 134 | MP0000716_abnormal_immune_system | 0.97032876 |
| 135 | MP0002272_abnormal_nervous_system | 0.96209825 |
| 136 | MP0003252_abnormal_bile_duct | 0.92953159 |
| 137 | MP0002398_abnormal_bone_marrow | 0.92841802 |
| 138 | MP0005023_abnormal_wound_healing | 0.91813459 |
| 139 | MP0000003_abnormal_adipose_tissue | 0.91060720 |
| 140 | MP0009764_decreased_sensitivity_to | 0.91045746 |
| 141 | MP0002095_abnormal_skin_pigmentation | 0.90891205 |
| 142 | MP0000689_abnormal_spleen_morphology | 0.90891145 |
| 143 | MP0001663_abnormal_digestive_system | 0.90825578 |
| 144 | MP0003786_premature_aging | 0.89588843 |
| 145 | MP0002693_abnormal_pancreas_physiology | 0.89280933 |
| 146 | MP0003137_abnormal_impulse_conducting | 0.89164163 |
| 147 | MP0001216_abnormal_epidermal_layer | 0.87274547 |
| 148 | MP0005220_abnormal_exocrine_pancreas | 0.86998642 |
| 149 | MP0002429_abnormal_blood_cell | 0.86158750 |
| 150 | MP0002722_abnormal_immune_system | 0.85204034 |
| 151 | MP0004019_abnormal_vitamin_homeostasis | 0.84148830 |
| 152 | MP0002557_abnormal_social/conspecific_i | 0.83515002 |
| 153 | MP0005636_abnormal_mineral_homeostasis | 0.83406649 |
| 154 | MP0009046_muscle_twitch | 0.82902837 |
| 155 | MP0004381_abnormal_hair_follicle | 0.82786133 |
| 156 | MP0004510_myositis | 0.82103782 |
| 157 | MP0010234_abnormal_vibrissa_follicle | 0.81112042 |
| 158 | MP0001970_abnormal_pain_threshold | 0.80891085 |
| 159 | MP0005397_hematopoietic_system_phenotyp | 0.80856942 |
| 160 | MP0001545_abnormal_hematopoietic_system | 0.80856942 |
| 161 | MP0000026_abnormal_inner_ear | 0.80713356 |
| 162 | MP0003718_maternal_effect | 0.80199097 |
| 163 | MP0001756_abnormal_urination | 0.80163919 |
| 164 | MP0005084_abnormal_gallbladder_morpholo | 0.80011665 |
| 165 | MP0002163_abnormal_gland_morphology | 0.79465480 |
| 166 | MP0005394_taste/olfaction_phenotype | 0.78679267 |
| 167 | MP0005499_abnormal_olfactory_system | 0.78679267 |
| 168 | MP0001243_abnormal_dermal_layer | 0.78445360 |
| 169 | MP0001765_abnormal_ion_homeostasis | 0.78395115 |
| 170 | MP0000470_abnormal_stomach_morphology | 0.78319467 |
| 171 | MP0002735_abnormal_chemical_nociception | 0.77565903 |
| 172 | MP0002909_abnormal_adrenal_gland | 0.77282686 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Congenital stationary night blindness (HP:0007642) | 4.10897404 |
| 2 | Pancreatic cysts (HP:0001737) | 3.83406160 |
| 3 | Molar tooth sign on MRI (HP:0002419) | 3.40674450 |
| 4 | Abnormality of midbrain morphology (HP:0002418) | 3.40674450 |
| 5 | Pancreatic fibrosis (HP:0100732) | 3.28437185 |
| 6 | Type II lissencephaly (HP:0007260) | 3.24203304 |
| 7 | True hermaphroditism (HP:0010459) | 3.15380935 |
| 8 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.14943296 |
| 9 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.10372420 |
| 10 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 3.10166355 |
| 11 | Generalized aminoaciduria (HP:0002909) | 3.09044966 |
| 12 | Increased CSF lactate (HP:0002490) | 3.08073499 |
| 13 | Hypoglycemic coma (HP:0001325) | 3.02398817 |
| 14 | Attenuation of retinal blood vessels (HP:0007843) | 3.00433674 |
| 15 | Acute necrotizing encephalopathy (HP:0006965) | 3.00250650 |
| 16 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.95283193 |
| 17 | Eczematoid dermatitis (HP:0000976) | 2.92291384 |
| 18 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.88345421 |
| 19 | Abolished electroretinogram (ERG) (HP:0000550) | 2.87997733 |
| 20 | Nephronophthisis (HP:0000090) | 2.84848153 |
| 21 | Hepatic necrosis (HP:0002605) | 2.77490893 |
| 22 | Cerebellar dysplasia (HP:0007033) | 2.76922320 |
| 23 | Abnormality of the renal cortex (HP:0011035) | 2.76817554 |
| 24 | Acute encephalopathy (HP:0006846) | 2.75276806 |
| 25 | 3-Methylglutaconic aciduria (HP:0003535) | 2.68782761 |
| 26 | Increased muscle lipid content (HP:0009058) | 2.67828721 |
| 27 | Xanthomatosis (HP:0000991) | 2.65738346 |
| 28 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.64922230 |
| 29 | Vacuolated lymphocytes (HP:0001922) | 2.63907144 |
| 30 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.61615040 |
| 31 | Abnormality of alanine metabolism (HP:0010916) | 2.61615040 |
| 32 | Hyperalaninemia (HP:0003348) | 2.61615040 |
| 33 | Hypoplasia of the pons (HP:0012110) | 2.58475581 |
| 34 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.55248012 |
| 35 | Medial flaring of the eyebrow (HP:0010747) | 2.51514107 |
| 36 | Abnormality of the renal medulla (HP:0100957) | 2.50849797 |
| 37 | Polydipsia (HP:0001959) | 2.50814593 |
| 38 | Abnormal drinking behavior (HP:0030082) | 2.50814593 |
| 39 | Dicarboxylic aciduria (HP:0003215) | 2.49571462 |
| 40 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.49571462 |
| 41 | Abnormal hemoglobin (HP:0011902) | 2.49538464 |
| 42 | Concave nail (HP:0001598) | 2.48816143 |
| 43 | Abnormality of the pons (HP:0007361) | 2.47396031 |
| 44 | Progressive macrocephaly (HP:0004481) | 2.43321902 |
| 45 | Recurrent abscess formation (HP:0002722) | 2.42481917 |
| 46 | Myoglobinuria (HP:0002913) | 2.42247136 |
| 47 | Ketosis (HP:0001946) | 2.36782671 |
| 48 | Decreased central vision (HP:0007663) | 2.35654843 |
| 49 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.35646800 |
| 50 | Nausea (HP:0002018) | 2.34598011 |
| 51 | Hypertriglyceridemia (HP:0002155) | 2.32643487 |
| 52 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.32266217 |
| 53 | Absent/shortened dynein arms (HP:0200106) | 2.32266217 |
| 54 | Tubular atrophy (HP:0000092) | 2.32107777 |
| 55 | Increased hepatocellular lipid droplets (HP:0006565) | 2.30615296 |
| 56 | Abnormal number of erythroid precursors (HP:0012131) | 2.30396833 |
| 57 | IgG deficiency (HP:0004315) | 2.30262498 |
| 58 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.28458796 |
| 59 | Thrombocytosis (HP:0001894) | 2.28116795 |
| 60 | Hyperglycinuria (HP:0003108) | 2.25041307 |
| 61 | Cystic liver disease (HP:0006706) | 2.24056781 |
| 62 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.23599071 |
| 63 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.23599071 |
| 64 | Hepatocellular necrosis (HP:0001404) | 2.23277892 |
| 65 | Methylmalonic aciduria (HP:0012120) | 2.23265774 |
| 66 | Ketoacidosis (HP:0001993) | 2.23186853 |
| 67 | Ventricular tachycardia (HP:0004756) | 2.22026010 |
| 68 | Recurrent bacterial skin infections (HP:0005406) | 2.21251584 |
| 69 | Rhabdomyolysis (HP:0003201) | 2.20917597 |
| 70 | Hyperammonemia (HP:0001987) | 2.20468152 |
| 71 | Multiple enchondromatosis (HP:0005701) | 2.20044564 |
| 72 | Increased serum lactate (HP:0002151) | 2.19772361 |
| 73 | Abnormality of the nasal mucosa (HP:0000433) | 2.16511938 |
| 74 | Renal Fanconi syndrome (HP:0001994) | 2.16506367 |
| 75 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.16241296 |
| 76 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.16241296 |
| 77 | Autoimmune thrombocytopenia (HP:0001973) | 2.16188313 |
| 78 | Lactic acidosis (HP:0003128) | 2.15846218 |
| 79 | Myocardial infarction (HP:0001658) | 2.15554284 |
| 80 | Increased serum ferritin (HP:0003281) | 2.14973782 |
| 81 | Sclerocornea (HP:0000647) | 2.14684496 |
| 82 | Optic disc pallor (HP:0000543) | 2.14562062 |
| 83 | Mesangial abnormality (HP:0001966) | 2.13398121 |
| 84 | Acanthosis nigricans (HP:0000956) | 2.13110074 |
| 85 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.12419811 |
| 86 | Retinal dysplasia (HP:0007973) | 2.10809407 |
| 87 | Microcytic anemia (HP:0001935) | 2.10216823 |
| 88 | Aplasia/hypoplasia of the uterus (HP:0008684) | 2.09556233 |
| 89 | Late onset (HP:0003584) | 2.08794862 |
| 90 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.08428122 |
| 91 | Urticaria (HP:0001025) | 2.07716691 |
| 92 | Hyperlipoproteinemia (HP:0010980) | 2.07627332 |
| 93 | Nasal polyposis (HP:0100582) | 2.07062881 |
| 94 | Chronic otitis media (HP:0000389) | 2.05378015 |
| 95 | Recurrent bronchitis (HP:0002837) | 2.04649395 |
| 96 | Severe muscular hypotonia (HP:0006829) | 2.03673402 |
| 97 | Cerebral palsy (HP:0100021) | 2.03526648 |
| 98 | Reticulocytopenia (HP:0001896) | 2.03141372 |
| 99 | Abnormality of macrophages (HP:0004311) | 2.00314454 |
| 100 | Increased intramyocellular lipid droplets (HP:0012240) | 2.00044578 |
| 101 | Polyuria (HP:0000103) | 1.99881697 |
| 102 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 1.99256816 |
| 103 | Conjunctival hamartoma (HP:0100780) | 1.99080548 |
| 104 | Congenital hepatic fibrosis (HP:0002612) | 1.98909449 |
| 105 | Pendular nystagmus (HP:0012043) | 1.98132890 |
| 106 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 1.97402568 |
| 107 | Lipoatrophy (HP:0100578) | 1.97369889 |
| 108 | Decreased circulating renin level (HP:0003351) | 1.96856539 |
| 109 | Absent thumb (HP:0009777) | 1.95317188 |
| 110 | Myositis (HP:0100614) | 1.94960740 |
| 111 | Abnormality of T cell physiology (HP:0011840) | 1.93877652 |
| 112 | Hyperglycinemia (HP:0002154) | 1.93859984 |
| 113 | Recurrent skin infections (HP:0001581) | 1.93626096 |
| 114 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.93276734 |
| 115 | Vertebral compression fractures (HP:0002953) | 1.91683884 |
| 116 | Asplenia (HP:0001746) | 1.91173745 |
| 117 | Renal cortical cysts (HP:0000803) | 1.91060405 |
| 118 | Aplasia/Hypoplasia of the patella (HP:0006498) | 1.90461939 |
| 119 | Right ventricular cardiomyopathy (HP:0011663) | 1.89888610 |
| 120 | Purpura (HP:0000979) | 1.89420406 |
| 121 | Abnormality of glycine metabolism (HP:0010895) | 1.89410417 |
| 122 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.89410417 |
| 123 | Lethargy (HP:0001254) | 1.89269552 |
| 124 | Abnormal biliary tract physiology (HP:0012439) | 1.89221430 |
| 125 | Bile duct proliferation (HP:0001408) | 1.89221430 |
| 126 | Colitis (HP:0002583) | 1.89158075 |
| 127 | Abnormality of iron homeostasis (HP:0011031) | 1.88953164 |
| 128 | Male pseudohermaphroditism (HP:0000037) | 1.88688386 |
| 129 | Patellar aplasia (HP:0006443) | 1.88433373 |
| 130 | Pancreatitis (HP:0001733) | 1.88421776 |
| 131 | Inflammation of the large intestine (HP:0002037) | 1.87622455 |
| 132 | Congenital, generalized hypertrichosis (HP:0004540) | 1.86945637 |
| 133 | Chronic hepatic failure (HP:0100626) | 1.86152192 |
| 134 | Cerebral edema (HP:0002181) | 1.86023565 |
| 135 | Gastrointestinal inflammation (HP:0004386) | 1.85407322 |
| 136 | Progressive microcephaly (HP:0000253) | 1.85233629 |
| 137 | Hypoalphalipoproteinemia (HP:0003233) | 1.85009559 |
| 138 | Agammaglobulinemia (HP:0004432) | 1.84831755 |
| 139 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.83341671 |
| 140 | Intrahepatic cholestasis (HP:0001406) | 1.83310230 |
| 141 | Cellulitis (HP:0100658) | 1.82712882 |
| 142 | Pustule (HP:0200039) | 1.82124170 |
| 143 | Large for gestational age (HP:0001520) | 1.81785915 |
| 144 | Skin rash (HP:0000988) | 1.81694095 |
| 145 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.80048112 |
| 146 | Recurrent fungal infections (HP:0002841) | 1.79256158 |
| 147 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.78813299 |
| 148 | Spontaneous hematomas (HP:0007420) | 1.78518601 |
| 149 | Amelogenesis imperfecta (HP:0000705) | 1.78132089 |
| 150 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.77587356 |
| 151 | Methylmalonic acidemia (HP:0002912) | 1.77556202 |
| 152 | Type I transferrin isoform profile (HP:0003642) | 1.77074196 |
| 153 | Abnormal cartilage morphology (HP:0002763) | 1.76633240 |
| 154 | Stomatitis (HP:0010280) | 1.76491729 |
| 155 | Deep venous thrombosis (HP:0002625) | 1.76142308 |
| 156 | Abnormal respiratory motile cilium physiology (HP:0012261) | 1.76036173 |
| 157 | Abnormality of urine glucose concentration (HP:0011016) | 1.75144539 |
| 158 | Glycosuria (HP:0003076) | 1.75144539 |
| 159 | Interstitial pulmonary disease (HP:0006530) | 1.75124188 |
| 160 | Hyperbilirubinemia (HP:0002904) | 1.74777553 |
| 161 | Lipid accumulation in hepatocytes (HP:0006561) | 1.74631336 |
| 162 | Clumsiness (HP:0002312) | 1.74233527 |
| 163 | Abnormal ciliary motility (HP:0012262) | 1.74205063 |
| 164 | Prostate neoplasm (HP:0100787) | 1.74131692 |
| 165 | Delayed CNS myelination (HP:0002188) | 1.74115681 |
| 166 | Type 2 muscle fiber atrophy (HP:0003554) | 1.74077653 |
| 167 | Abnormality of T cells (HP:0002843) | 1.73740210 |
| 168 | Dilated cardiomyopathy (HP:0001644) | 1.71935449 |
| 169 | Macrocytic anemia (HP:0001972) | 1.71168186 |
| 170 | Insulin resistance (HP:0000855) | 1.71119176 |
| 171 | Abnormality of complement system (HP:0005339) | 1.69541440 |
| 172 | Prolonged partial thromboplastin time (HP:0003645) | 1.68802480 |
| 173 | Asymmetric septal hypertrophy (HP:0001670) | 1.68528433 |
| 174 | IgM deficiency (HP:0002850) | 1.67217702 |
| 175 | Paralysis (HP:0003470) | 1.66934303 |
| 176 | Mitochondrial inheritance (HP:0001427) | 1.66612044 |
| 177 | Papilloma (HP:0012740) | 1.65930618 |
| 178 | Verrucae (HP:0200043) | 1.65930618 |
| 179 | Petechiae (HP:0000967) | 1.64986151 |
| 180 | Exertional dyspnea (HP:0002875) | 1.64590645 |
| 181 | Hypergammaglobulinemia (HP:0010702) | 1.64538549 |
| 182 | Abnormality of T cell number (HP:0011839) | 1.63599015 |
| 183 | Systemic lupus erythematosus (HP:0002725) | 1.63560016 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 3.97491787 |
| 2 | BCKDK | 3.57971675 |
| 3 | NME2 | 3.55822012 |
| 4 | ERN1 | 3.20617433 |
| 5 | ADRBK2 | 3.06146134 |
| 6 | TRIB3 | 3.02448664 |
| 7 | ZAK | 2.93620726 |
| 8 | GRK1 | 2.81964304 |
| 9 | VRK2 | 2.66516314 |
| 10 | BMPR1B | 2.58222920 |
| 11 | MAP4K1 | 2.55261910 |
| 12 | TBK1 | 2.33195183 |
| 13 | MUSK | 2.30796068 |
| 14 | NUAK1 | 2.30444054 |
| 15 | WNK4 | 2.27370524 |
| 16 | MAP4K2 | 2.25960684 |
| 17 | IRAK3 | 2.13171548 |
| 18 | KDR | 2.04892001 |
| 19 | PIM2 | 2.01959689 |
| 20 | BLK | 1.97510571 |
| 21 | IRAK4 | 1.92989318 |
| 22 | IKBKE | 1.92422051 |
| 23 | MAP3K14 | 1.87019535 |
| 24 | INSRR | 1.82657008 |
| 25 | TYK2 | 1.80230653 |
| 26 | FGFR4 | 1.79207107 |
| 27 | PINK1 | 1.69951722 |
| 28 | JAK3 | 1.69759715 |
| 29 | MAPK13 | 1.64711986 |
| 30 | ACVR1B | 1.63784549 |
| 31 | LRRK2 | 1.56661195 |
| 32 | ZAP70 | 1.50116281 |
| 33 | TLK1 | 1.47968331 |
| 34 | FLT3 | 1.46391263 |
| 35 | WNK3 | 1.43728644 |
| 36 | RPS6KA4 | 1.41904724 |
| 37 | PKN2 | 1.41770899 |
| 38 | MYLK | 1.41464238 |
| 39 | IKBKB | 1.39341746 |
| 40 | MAPKAPK3 | 1.39245248 |
| 41 | MAP3K3 | 1.39145710 |
| 42 | TNK2 | 1.35733395 |
| 43 | NEK9 | 1.35237215 |
| 44 | TTN | 1.31814534 |
| 45 | MAP2K2 | 1.29506996 |
| 46 | PIK3CG | 1.27963181 |
| 47 | MST4 | 1.27740078 |
| 48 | TESK2 | 1.26795523 |
| 49 | NLK | 1.25598566 |
| 50 | TGFBR2 | 1.25353002 |
| 51 | MAP2K3 | 1.22732613 |
| 52 | STK10 | 1.20820419 |
| 53 | TESK1 | 1.20820046 |
| 54 | ADRBK1 | 1.17132834 |
| 55 | SIK1 | 1.16816922 |
| 56 | VRK1 | 1.14871718 |
| 57 | KIT | 1.13744215 |
| 58 | MAP3K11 | 1.11839511 |
| 59 | STK16 | 1.11330251 |
| 60 | STK39 | 1.11287251 |
| 61 | ILK | 1.10037879 |
| 62 | EPHB1 | 1.07323850 |
| 63 | MAP2K6 | 1.06550669 |
| 64 | TEC | 1.03427904 |
| 65 | BTK | 1.02360407 |
| 66 | TXK | 1.01293591 |
| 67 | CSK | 0.97580037 |
| 68 | PRKCI | 0.95852684 |
| 69 | PHKG2 | 0.93109270 |
| 70 | PHKG1 | 0.93109270 |
| 71 | PTK2B | 0.93076910 |
| 72 | DYRK2 | 0.92780990 |
| 73 | MAPK11 | 0.88699998 |
| 74 | PIM1 | 0.88669589 |
| 75 | MAP3K10 | 0.88150953 |
| 76 | DAPK2 | 0.87690916 |
| 77 | LIMK1 | 0.87262087 |
| 78 | PRKCQ | 0.86631013 |
| 79 | JAK1 | 0.83845220 |
| 80 | IRAK1 | 0.82307529 |
| 81 | ABL2 | 0.77021225 |
| 82 | EIF2AK1 | 0.76116262 |
| 83 | MAP2K7 | 0.74592210 |
| 84 | DYRK1B | 0.74044020 |
| 85 | PBK | 0.74024232 |
| 86 | CHUK | 0.73794013 |
| 87 | OXSR1 | 0.72646853 |
| 88 | PIK3CA | 0.72452608 |
| 89 | DAPK3 | 0.70139143 |
| 90 | STK4 | 0.69258631 |
| 91 | TIE1 | 0.68513326 |
| 92 | EPHA3 | 0.68466996 |
| 93 | CSNK1G3 | 0.68298102 |
| 94 | NME1 | 0.67358560 |
| 95 | TRPM7 | 0.66251251 |
| 96 | PRKD2 | 0.66169811 |
| 97 | TGFBR1 | 0.65797551 |
| 98 | JAK2 | 0.65223717 |
| 99 | MST1R | 0.64081370 |
| 100 | SYK | 0.63871622 |
| 101 | ITK | 0.63649200 |
| 102 | PTK6 | 0.63594091 |
| 103 | CDK19 | 0.62201526 |
| 104 | MAPK15 | 0.62191050 |
| 105 | PRKCE | 0.61823804 |
| 106 | TAOK3 | 0.61331469 |
| 107 | LCK | 0.61241567 |
| 108 | IRAK2 | 0.60887770 |
| 109 | OBSCN | 0.60348676 |
| 110 | MAPKAPK2 | 0.60062893 |
| 111 | GRK7 | 0.59056786 |
| 112 | PRKG2 | 0.58998303 |
| 113 | RPS6KA5 | 0.58671707 |
| 114 | CSNK1G1 | 0.57854246 |
| 115 | MAP3K8 | 0.57292613 |
| 116 | MARK3 | 0.54846444 |
| 117 | GRK5 | 0.54543060 |
| 118 | EPHB2 | 0.54441658 |
| 119 | CSNK1G2 | 0.54038014 |
| 120 | HIPK2 | 0.53595584 |
| 121 | CDK9 | 0.53291878 |
| 122 | GRK6 | 0.53201687 |
| 123 | CCNB1 | 0.52733321 |
| 124 | CSF1R | 0.52031076 |
| 125 | LYN | 0.50954513 |
| 126 | PRKCG | 0.49358125 |
| 127 | CDK8 | 0.48808945 |
| 128 | DYRK3 | 0.48076298 |
| 129 | ARAF | 0.47902052 |
| 130 | PRKD1 | 0.47407961 |
| 131 | CSNK1A1 | 0.46212067 |
| 132 | PRKAA2 | 0.45738489 |
| 133 | FGFR3 | 0.45257473 |
| 134 | EEF2K | 0.45165822 |
| 135 | RPS6KB2 | 0.44227660 |
| 136 | PRKACA | 0.43312384 |
| 137 | PKN1 | 0.43004672 |
| 138 | STK11 | 0.42832092 |
| 139 | CSNK1A1L | 0.42746027 |
| 140 | EPHA2 | 0.42264543 |
| 141 | RIPK1 | 0.40213568 |
| 142 | MAP3K4 | 0.39482168 |
| 143 | PAK3 | 0.39452223 |
| 144 | STK24 | 0.39015518 |
| 145 | PRKCA | 0.38205191 |
| 146 | CAMK1 | 0.37487849 |
| 147 | RPS6KA6 | 0.37197369 |
| 148 | CAMKK2 | 0.36700569 |
| 149 | HCK | 0.35532971 |
| 150 | PRKCZ | 0.35513450 |
| 151 | CDK6 | 0.32791791 |
| 152 | DMPK | 0.30202040 |
| 153 | ABL1 | 0.29593826 |
| 154 | PRKD3 | 0.29286600 |
| 155 | TAOK2 | 0.29140820 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ribosome_Homo sapiens_hsa03010 | 2.83918415 |
| 2 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.83474529 |
| 3 | RNA polymerase_Homo sapiens_hsa03020 | 2.36409002 |
| 4 | Protein export_Homo sapiens_hsa03060 | 2.31849339 |
| 5 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.28056593 |
| 6 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.27395518 |
| 7 | Phototransduction_Homo sapiens_hsa04744 | 2.18616173 |
| 8 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.97986505 |
| 9 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.82279763 |
| 10 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.80991305 |
| 11 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.80718797 |
| 12 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.79039266 |
| 13 | Huntingtons disease_Homo sapiens_hsa05016 | 1.78482305 |
| 14 | Sulfur relay system_Homo sapiens_hsa04122 | 1.75554741 |
| 15 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.72294087 |
| 16 | Peroxisome_Homo sapiens_hsa04146 | 1.66672886 |
| 17 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.66027692 |
| 18 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.62835206 |
| 19 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.62071494 |
| 20 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.61551133 |
| 21 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.59231103 |
| 22 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.55347553 |
| 23 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.52907030 |
| 24 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.51709175 |
| 25 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.50976216 |
| 26 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.50332957 |
| 27 | Asthma_Homo sapiens_hsa05310 | 1.48041571 |
| 28 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.46606085 |
| 29 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.46334375 |
| 30 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.41866823 |
| 31 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.41471120 |
| 32 | Homologous recombination_Homo sapiens_hsa03440 | 1.40952479 |
| 33 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.40846271 |
| 34 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.40115614 |
| 35 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.37406463 |
| 36 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.35811190 |
| 37 | Leishmaniasis_Homo sapiens_hsa05140 | 1.35223164 |
| 38 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.31778937 |
| 39 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.31419322 |
| 40 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.27677176 |
| 41 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.24557212 |
| 42 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.22765075 |
| 43 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.22353166 |
| 44 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.22031299 |
| 45 | Histidine metabolism_Homo sapiens_hsa00340 | 1.21360257 |
| 46 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.21186822 |
| 47 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.20825831 |
| 48 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.18606879 |
| 49 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.12869895 |
| 50 | Other glycan degradation_Homo sapiens_hsa00511 | 1.12860524 |
| 51 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.12686712 |
| 52 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.12165871 |
| 53 | Parkinsons disease_Homo sapiens_hsa05012 | 1.11196315 |
| 54 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.08292767 |
| 55 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.08199795 |
| 56 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.07653982 |
| 57 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.06626474 |
| 58 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.06603230 |
| 59 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.06589878 |
| 60 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.06577613 |
| 61 | Carbon metabolism_Homo sapiens_hsa01200 | 1.06503615 |
| 62 | Legionellosis_Homo sapiens_hsa05134 | 1.06393738 |
| 63 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.04704247 |
| 64 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.04403003 |
| 65 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.01610301 |
| 66 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.01030004 |
| 67 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.00416901 |
| 68 | Malaria_Homo sapiens_hsa05144 | 0.99638444 |
| 69 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.99123276 |
| 70 | Measles_Homo sapiens_hsa05162 | 0.98228843 |
| 71 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.97943288 |
| 72 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.96821946 |
| 73 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.94638415 |
| 74 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.93861274 |
| 75 | Basal transcription factors_Homo sapiens_hsa03022 | 0.92531353 |
| 76 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.92123822 |
| 77 | Allograft rejection_Homo sapiens_hsa05330 | 0.88008845 |
| 78 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.87439533 |
| 79 | Proteasome_Homo sapiens_hsa03050 | 0.84593971 |
| 80 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.84124785 |
| 81 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.83875026 |
| 82 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.81517212 |
| 83 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.81362170 |
| 84 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.81289906 |
| 85 | Purine metabolism_Homo sapiens_hsa00230 | 0.81253195 |
| 86 | Pertussis_Homo sapiens_hsa05133 | 0.76939859 |
| 87 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.76028508 |
| 88 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.75765762 |
| 89 | Base excision repair_Homo sapiens_hsa03410 | 0.75494302 |
| 90 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.74680489 |
| 91 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.73959949 |
| 92 | RNA degradation_Homo sapiens_hsa03018 | 0.73316992 |
| 93 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.72389702 |
| 94 | Viral myocarditis_Homo sapiens_hsa05416 | 0.72221153 |
| 95 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.70045421 |
| 96 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.70022381 |
| 97 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.68816890 |
| 98 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.68122318 |
| 99 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.67245673 |
| 100 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.66401715 |
| 101 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.65782082 |
| 102 | ABC transporters_Homo sapiens_hsa02010 | 0.64713509 |
| 103 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.64224186 |
| 104 | Olfactory transduction_Homo sapiens_hsa04740 | 0.64057688 |
| 105 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.63871855 |
| 106 | Retinol metabolism_Homo sapiens_hsa00830 | 0.63029248 |
| 107 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.62703285 |
| 108 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.62666289 |
| 109 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.61317007 |
| 110 | Alzheimers disease_Homo sapiens_hsa05010 | 0.60795570 |
| 111 | Apoptosis_Homo sapiens_hsa04210 | 0.60539329 |
| 112 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.60493827 |
| 113 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.60435722 |
| 114 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.59706972 |
| 115 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.58402535 |
| 116 | Taste transduction_Homo sapiens_hsa04742 | 0.57818171 |
| 117 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.57571858 |
| 118 | Lysosome_Homo sapiens_hsa04142 | 0.57265762 |
| 119 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.57076789 |
| 120 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.55333776 |
| 121 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.52451222 |
| 122 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.51515303 |
| 123 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.51093122 |
| 124 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.50698733 |
| 125 | Shigellosis_Homo sapiens_hsa05131 | 0.49864887 |
| 126 | Influenza A_Homo sapiens_hsa05164 | 0.49690088 |
| 127 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.49567067 |
| 128 | Nicotine addiction_Homo sapiens_hsa05033 | 0.47779326 |
| 129 | Insulin resistance_Homo sapiens_hsa04931 | 0.47420192 |
| 130 | Metabolic pathways_Homo sapiens_hsa01100 | 0.46456206 |
| 131 | Galactose metabolism_Homo sapiens_hsa00052 | 0.46049122 |
| 132 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.45182333 |
| 133 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.43261815 |
| 134 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.42990295 |
| 135 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.40938375 |
| 136 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.35846218 |
| 137 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.34179905 |
| 138 | Morphine addiction_Homo sapiens_hsa05032 | 0.31609322 |

